Metabolic dysfunction-associated fatty liver disease is an independent risk factor for advanced colorectal adenoma or cancer.

BACKGROUND Metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to compensate for the conventional concept of nonalcoholic fatty liver disease (NAFLD). We investigated whether MAFLD or its respective subtypes were associated with the risk of advanced colorectal neoplasia (ACN), including age-specific associations. METHODS This single-centre retrospective study included 21 642 participants who underwent medical health check-ups. Participants were categorised by fatty liver disease presence (NAFLD or MAFLD). Patients with MAFLD were categorised into three subtypes: overweight-MAFLD, lean-MAFLD, and diabetes-MAFLD. The fibrosis-4 index assessed hepatic fibrotic burden. RESULTS Both NAFLD and MAFLD were significantly associated with nonadvanced colorectal neoplasia risk [odds ratio (OR) = 1.19 and 1.34, respectively; P < 0.05]. In contrast, NAFLD was not significantly associated with ACN risk. Multivariate analysis showed that MAFLD was independently associated with increased ACN risk (OR = 1.20, P < 0.05). Among MAFLD subtypes, diabetes-MAFLD alone was independently associated with increased ACN risk (OR = 1.56, P < 0.05). This MAFLD-ACN association was significant only in patients aged less than or equal to 50 years (OR = 2.54 for 30-39 years and OR = 1.43 for 40-49 years, all P < 0.05). High hepatic fibrotic burden (fibrosis-4 greater than or equal to 1.3) was associated with higher ACN risk in MAFLD patients (OR = 1.31, P < 0.05). CONCLUSION MAFLD was independently associated with an increased risk of ACN; however, this association differed according to age and MAFLD subtype. Patients with MAFLD, especially those with high fibrotic burden, underlying diabetes, or aged less than or equal to 50 years, may benefit from appropriate colorectal cancer screening.

• Publication year

  2026

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2026-02-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0000000000003148PMID 41784423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of diabetes mellitus with early-onset colorectal cancer: A systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events.

  2023cited by this paper
• Metabolic Dysfunction–Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study

  2022cited by this paper
• Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name

  2022cited by this paper
• Metabolism and Colorectal Cancer.

  2022cited by this paper
• Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population

  2022cited by this paper
• Association between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed before 50 years According to Tumor Location.

  2022cited by this paper
• Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update.

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease

  2021cited by this paper
• Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study

  2021cited by this paper
• Skeletal muscle mass and risk of advanced adenoma in surveillance colonoscopy

  2020cited by this paper
• Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults.

  2020cited by this paper
• A new definition for metabolic associated fatty liver disease: an international expert consensus statement.

  2020cited by this paper
• Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy

  2020cited by this paper
• High risk of colorectal polyps in men with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

  2020cited by this paper
• History of Nonalcoholic Fatty Liver Disease

  2020cited by this paper
• Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.

  2020cited by this paper
• Global patterns and trends in colorectal cancer incidence in young adults

  2019cited by this paper
• Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

  2018cited by this paper
• Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.

  2018cited by this paper
• Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC

  2017cited by this paper
• Comparing Clinical Characteristics and Outcomes of Young‐onset and Late‐onset Colorectal Cancer: An International Collaborative Study

  2017cited by this paper
• Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease

  2016cited by this paper
• Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

  2015cited by this paper
• Adenoma detection rate and risk of colorectal cancer and death.

  2014cited by this paper
• Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer.

  2013cited by this paper
• The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

  2012cited by this paper
• Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans

  2011cited by this paper
• The advanced adenoma as the primary target of screening.

  2002cited by this paper

• No citing papers are available for this paper.